Skip to main content

Day: April 7, 2021

Cavitation Technologies, Inc. Signs a Pilot Test Agreement with Island Breeze Farms

Chatsworth, CA, April 07, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Cavitation Technologies, Inc. (OTCQB: CVAT) (BERLIN: WTC) has signed a pilot test agreement with Island Breeze Farms. The agreement is meant to evaluate CVAT’s technology and the growth of healthier cannabis plants with increased crop yields. Island Breeze Farms is a Licensed Cannabis grower in Southern California, operating a 130,000 square foot greenhouse facility. CVAT’s technology and nanotech water system substantially increases the amount of molecular oxygen in water. As cannabis plant roots absorb the molecular oxygen, Nano bubbles continue to replace lost oxygen, resulting in a stable elevated level of oxygen. This stable elevated level of oxygen produces a cleaner and more efficient method of irrigation, resulting in healthier plants with increased...

Continue reading

The Samsung A-series is coming to Verizon led by the affordable Galaxy A42 5G

BASKING RIDGE, N.J., April 07, 2021 (GLOBE NEWSWIRE) — Verizon is your home for the 2021 Samsung Galaxy A series smartphones, including the powerful new Galaxy A42 5G, Galaxy A12 and the Galaxy A02s. The latest Galaxy A series is packed with awesome features at a price that works for everyone. Take stunning shots with powerful multi-camera systems, see immersive content on vivid displays and enjoy peace of mind with long-lasting, fast-charging batteries. Here’s why they are awesome. Galaxy A42 5G connects you to Verizon’s 5G Ultra Wideband and 5G Nationwide network, offering the potential for unprecedented speed and power that brings out the best in your new Galaxy phone. Take amazing photos and 4K videos with the Galaxy A42 5G’s 48 MP triple camera system enhanced by popular Galaxy features like Super Steady and Single Take. Bring...

Continue reading

Cullinan Oncology, Inc. to Participate in the 20th Annual Needham Virtual Healthcare Conference

CAMBRIDGE, Mass., April 07, 2021 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM) (“Cullinan”) announced today that the company’s Chief Financial Officer, Jeff Trigilio, will present at the upcoming 20th Annual Needham Virtual Healthcare Conference. Event: Needham Virtual Healthcare ConferenceDate: Tuesday, April 13thTime: 11:45am EDTLocation: Virtual The presentation will be accessible through the Needham conference portal for registered attendees only. Investors interested in scheduling a meeting with Mr. Trigilio should contact their Needham & Company representative. About Cullinan Oncology Cullinan Oncology is a biopharmaceutical company that seeks to drive shareholder returns by focusing on the patient. The Company’s strategy is to build a diversified pipeline of targeted and immuno-oncology therapeutic candidates...

Continue reading

Sjóvá: Skýrsla um gjaldþol og fjárhagslega stöðu 2020 (SFCR)

Sjóvá-Almennar tryggingar hf. hefur gefið út skýrslu um gjaldþol og fjárhagslega stöðu fyrir árið 2020. Skýrslan er gefin út í samræmi við kröfur laga um vátryggingastarfsemi nr. 100/2016. Skýrslunni er m.a. ætlað að veita almenningi og markaðsaðilum upplýsingar um fjárhagslegan styrk, áhættu, eignir og skuldir félagsins og talnaupplýsingar. Skýrsluna sjálfa ásamt talnaefni má finna á eftirfarandi síðu: https://www.sjova.is/um-okkur/fjarfestar/fjarhagsupplysingar/2020/

Continue reading

Invesco Ltd.: Form 8.3 – UK 8.3 Bally’s Corporation

FORM 8.3 PUBLIC DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Invesco Ltd.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Bally’s Corporation  (d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:    (e) Date position held/dealing undertaken:For an opening position disclosure, state the latest practicable date prior...

Continue reading

Depression Treatment Therapy Market 2021 | Size, Share, Growth, Trends, Analysis, Competitive Landscape, Revenue, Forecast Report 2021-2028

Pune, India, April 07, 2021 (GLOBE NEWSWIRE) — The global ”depression treatment therapy market” size is expected to gain momentum backed by the increasing incidence of suicides and the growing number of psychiatrists that is likely to boost the adoption of advanced depression treatment therapy modules worldwide. This information is published by Fortune Business Insights in its upcoming report, titled, “Depression Treatment Therapy Market Size, Share & Industry Analysis, By Type (Medications, Devices), By Disease Indication (Major Depression, Bipolar Depression, Seasonal Affective Disorder (SAD), Premenstrual Dysphoric Disorder (PMDD), Others), By End User (Hospitals, Specialty Clinics, Others) and Regional Forecast 2020-2027.” The effect of the global pandemic, COVID-19, has been felt across several economies that are facing...

Continue reading

Fuel Cell Market Eyeing Phenomenal Growth at a healthy CAGR of 14.5% | Market Research Future (MRFR)

Pune, April 07, 2021 (GLOBE NEWSWIRE) — The global fuel cell technology market is anticipated to grow at a stellar 14.5% CAGR over the forecast period (2020- 2027), reveals the current Market Research Future (MRFR) report. The energy produced by a device after conversion to electrical from chemical due to chemical reaction of hydrogen ions that are positively charged with the oxidizing agent is called a fuel cell. These cells need constant feeding of air or fuel to retain the reaction.  Enhancing Features that Boost Fuel Cell Technology Market  As per the MRFR report, there are numerous factors that are propelling the fuel cell technology market share. Some of these include increased demand for reliable alternative energy, growing concerns over growing ecology issues that are prompting the requirement for alternative energy generation...

Continue reading

Telerehabilitation Market Size 2021 | To Exhibit 13.4% CAGR and Hit USD 9.13 Billion by 2027

Pune, India, April 07, 2021 (GLOBE NEWSWIRE) — The global telerehabilitation market size is poised to rise remarkably in the coming years attributable to the technological advancements in the field of healthcare services in collaboration with information, technology, and communications. Telerehabilitation is a medical service for people preferring to stay at home and avail treatment and services. As per a recent report by Fortune Business Insights, titled, “Telerehabilitation Market Size, Share and Covid-19 Impact Analysis, By Type (Products, Services), By Application (Occupational Therapy, Physical Therapy, Chronic Diseases, and Others), By End-User (Healthcare Facilities and Homecare); and Regional Forecast, 2020-2027,” the market value stood at USD 3.32 billion in 2019 and is expected to rise at a CAGR of 13.4% to reach USD 9.13...

Continue reading

Pranav Nawani, PhD, joins Andrew Spencer and David E. Burnett on Puget Technologies, Inc.’s Board of Advisors

BOCA RATON, Fla., April 07, 2021 (GLOBE NEWSWIRE) — Puget Technologies, Inc. (“Puget”; Pink Open Market symbol “PUGE”), a Nevada corporation subject to reporting pursuant to Sections 13 and 15(d) of the Securities Exchange Act of 1934, as amended, is pleased to announce that Dr. Pranav Nawani has joined its Board of Advisors. Dr. Nawani, age 47, is a Research Scientist at Washington State University’s Institute for Shock Physics, Applied Sciences Laboratory. Dr. Nawani has a long trajectory investigating issues related to nanomaterials and polymer nanocomposite materials research and his research lies at the confluence of polymer chemistry, polymer physics, applied chemistry, material science, and biomaterials. Dr. Nawani’s research interests are focused on developing advanced materials and polymer nanocomposites for applications...

Continue reading

AGF Reports March 2021 Assets Under Management

TORONTO, April 07, 2021 (GLOBE NEWSWIRE) — AGF Management Limited reported total fee-earning assets under management (AUM) of $40.5 billion as at March 31, 2021.  AUM ($ billions)March 31,2021 February 28,2021 % ChangeMonth-Over-Month March 31,2020 % ChangeYear-Over-YearTotal Mutual Fund (including retail pooled funds) $21.8 $21.4   $16.7  Institutional and Sub-advisory +High-net-worth + Exchange-traded funds $16.0 $15.7   $14.7  Subtotal(before Private Alternative AUM) $37.8 $37.1   $31.4  Private Alternative AUM $2.7 $2.7   $2.9  Total AUM $40.5 $39.8 1.8% $34.3 18.1%           Average Daily Mutual Fund AUM $21.6 $21.6   $17.1  Mutual Fund AUM by Category(including retail pooled funds) ($ billions)March 31,2021 February 28,2021 March 31,2020Domestic Equity Funds $3.9 $3.7 $3.0U.S. and International...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.